Keyphrases
Thrombotic
100%
ADAMTS13
100%
Thrombotic Thrombocytopenic Purpura
75%
Heat-inactivated
31%
Immune Thrombocytopenia
25%
Plasma Samples
25%
Healthy Donors
18%
Thrombotic Microangiopathy
18%
Calcium Chloride
12%
Platelet Factor 4
12%
Clinical Symptoms
12%
Activity Level
12%
Patient Samples
12%
Cattle
12%
HEPES
6%
Metal Chelates
6%
Treatment-seeking Sample
6%
Tween 20
6%
Activity Test
6%
Platelet Adhesion
6%
Treatment Stage
6%
Renal Insufficiency
6%
Duke University
6%
Blood Clotting Disorder
6%
Chelating Effect
6%
Vascular Damage
6%
Diverse Patient Population
6%
Neurological Abnormalities
6%
Malignant Hypertension
6%
Von Willebrand Factor
6%
Metalloprotease
6%
Thrombocytopenia
6%
Citrate
6%
Anemia
6%
Autoimmune
6%
Healthy Controls
6%
Fever
6%
Pertinent Information
6%
Platelet Factor 4 Antibodies
6%
Heparin-induced Thrombocytopenia
6%
Blinded Study
6%
Masquerade
6%
Atypical Hemolytic Uremic Syndrome (aHUS)
6%
Genetic Deficiency
6%
Clinical Utility
6%
Sodium Chloride
6%
Population Control
6%
Pharmacology, Toxicology and Pharmaceutical Science
Thrombosis
100%
Von Willebrand Factor Cleaving Proteinase
100%
Thrombotic Thrombocytopenic Purpura
75%
Idiopathic Thrombocytopenic Purpura
25%
Thrombocyte Factor 4
18%
Symptom
18%
Microangiopathy
18%
Bovine
12%
Calcium Chloride
12%
Malignant Hypertension
6%
HEPES
6%
Hemolytic Uremic Syndrome
6%
Hemostatic Agent
6%
Blood Vessel Injury
6%
Polysorbate 20
6%
Blood Clotting Disorder
6%
Von Willebrand Factor
6%
Syndrome
6%
Heparin Induced Thrombocytopenia
6%
Buffer
6%
Metalloproteinase
6%
Kidney Failure
6%
Anemia
6%
Thrombocytopenia
6%
Medicine and Dentistry
Von Willebrand Factor Cleaving Proteinase
100%
Thrombosis
100%
Thrombotic Thrombocytopenic Purpura
75%
Idiopathic Thrombocytopenic Purpura
25%
Thrombocyte Factor 4
18%
Microangiopathy
18%
Symptom
18%
Calcium Chloride
12%
Patient Population
6%
Polysorbate 20
6%
Blood Vessel Injury
6%
Thrombocyte Adhesion
6%
Anemia
6%
HEPES
6%
Blood Donor
6%
Thrombocytopenia
6%
Von Willebrand Factor
6%
Hemostat
6%
Metalloproteinase
6%
Renal Failure
6%
Malignant Hypertension
6%
Atypical Hemolytic Uremic Syndrome
6%
Buffer
6%
Heparin-Induced Thrombocytopenia
6%
Coagulopathy
6%
